In critical care, time is not just an important factor; there needs to be decisive action as well.
Laboratory results directly inform medical decisions, such as adjusting a ventilator or treating a poisoned patient. Traditional arterial blood gas (ABG) testing is central to this process. It delivers rapid insight into blood pH, oxygen and carbon dioxide levels along with acid-base balance.
However, there is one critical blind spot that ABG leaves out: it assumes that hemoglobin is normal and capable of transporting oxygen.
This is why it is important to explore CO-oximetry in detail: what it is, when the time is right to use it and the parameters it can measure. It’s also critical to consider its integration with ABG testing and the analyzer options that labs can consider when implementing this technology.
In truth, not every hemoglobin molecule functions as they should. Some are bound to carbon monoxide while others are oxidized to a form that prevents oxygen from being carried.
This abnormality known as dyshemoglobins can cause life-threatening hypoxia even when ABG values look normal. A patient’s pOâ‚‚ might be satisfactory, but if a significant fraction of hemoglobin is bound to carbon monoxide or oxidized to methemoglobin, then the tissues may still be deprived of oxygen.
This is where CO-oximetry becomes indispensable. Unlike ABG or pulse oximetry, CO-oximetry directly measures hemoglobin derivatives which includes oxyhemoglobin, deoxyhemoglobin and more. The test helps to narrow the diagnostic gap by providing clinicians with reliable and real-time data regarding oxygen delivery capacity.
It contains broad applications. This ranges from smoke inhalation testing to treatment monitoring for CO poisoning and identifying methemoglobinemia causes in toxicology. Co-oximetry is at the center of rapid, accurate decision-making.
In ICU respiratory failure testing, it prevents hidden dyshemoglobins from complicating ventilator management. Likewise, in neonatal care, neonatal co-oximetry offers precise monitoring for the type of patients that are vulnerable.
Modern and trusted vendors play a unique role in making this capability widely accessible. Their portfolios of refurbished Siemens RAPIDLab analyzers, including the RAPIDLab 1265 and RAPIDLab 348BGA analyzer provide hospitals and labs with cost-effective, co-oximetry-enabled systems.
With customizable menus and optional add-on modules, these analyzers can be configured to meet the specific clinical demands of each facility.
Thanks to the Down-To-Frame® refurbishment process as well, facilities gain access to instruments that are rebuilt to like-new quality. This service is also supported by comprehensive QC solutions.
CO-oximetry is based on spectrophotometry. A blood sample is exposed to multiple wavelengths of light and each hemoglobin species absorbs light differently. Through the analysis of the absorption pattern, analyzers can determine the proportions of oxyhemoglobin (Oâ‚‚Hb) carboxyhemoglobin (COHb) and more.
There are some systems that also measure sulfhemoglobin (SHb). This is less common however.
This is fundamentally different from pulse oximetry, which only uses around two wavelengths of light and assumes hemoglobin species are normal. This assumption can be dangerously misleading in conditions like carbon monoxide poisoning.
Similarly, ABG analyzers estimate oxygen saturation based on pOâ‚‚ but do not directly measure hemoglobin functionality.
By providing direct measurement, CO-oximetry uncovers hidden hypoxia that other methods miss. It's the only way to reliably quantify dyshemoglobins at the point of care.
Smoke inhalation testing is perhaps the best-known use. Fire victims inhale carbon monoxide, binding hemoglobin with 200 times the affinity of oxygen.
Pulse oximetry often shows falsely reassuring results, while ABG oxygen values can appear to be normal. Only carboxyhemoglobin testing can reveal the true extent of carbon monoxide exposure.
With rapid results, clinicians can decide whether to initiate high-flow oxygen therapy or escalate to hyperbaric oxygen treatment.
Methemoglobinemia is another critical condition. It can be caused by exposure to oxidizing drugs such as dapsone, nitrates in contaminated water or certain local anesthetics. It can also result from rare congenital enzyme deficiencies.
Despite the methemoglobinemia causes, the outcome remains the same.
That being hemoglobin is oxidized to a ferric form that cannot carry oxygen. Cyanosis unresponsive to oxygen therapy is often the first clue.
Methemoglobin testing confirms the diagnosis while ongoing measurements guide treatments such as methylene blue therapy or alternative supportive measures.
In intensive care, ICU respiratory failure testing benefits greatly from co-oximetry. A patient may present with hypoxemia and ventilator settings are adjusted accordingly.
Yet if COHb or MetHb levels are elevated, lung adjustments fail to resolve the underlying oxygen delivery problem. Without co-oximetry treatment might be delayed or ineffective.
Neonatal co-oximetry is another vital application.
Infants may be exposed to oxidants or drugs, increasing methemoglobin levels. Since their hemoglobin physiology differs from adults, they are more vulnerable to dyshemoglobins.
Small blood sample volumes that are coupled with the need for precise monitoring can make co-oximetry-enabled analyzers critical in neonatal intensive care units.
Treatment monitoring CO poisoning requires serial COHb measurements to ensure effective therapy. Co-oximetry is the only way to track progress in real time. This gives clinicians the confidence that interventions are working.
The most important co-oximeter parameters include:
Together, these parameters provide a complete picture of the hemoglobin status, ensuring clinicians are not misled by partial data from ABG or pulse oximetry.
The ability to perform co-oximetry with ABG streamlines the workflow and speeds up diagnosis. A single sample yields traditional blood gas values and hemoglobin fractions. This is particularly important in an emergency setting, as time would be limited and sample collection has to be minimized.
Refurbished analyzers such as the Siemens RAPIDLab 1265 are a prime example of this integration.
Designed for critical care, they integrate blood gases, electrolytes, metabolites and co-oximetry into one menu.
Clinicians can view pH, pCOâ‚‚, dyshemoglobin levels and more in one consolidated report. This comprehensive view supports rapid and informed decisions.
The Siemens RAPIDLab 348 is another model widely available through resourceful providers. While focused on blood gases, pH and electrolytes, there are certain configurations that include co-oximetry parameters. It offers reliable performance with menu options tailored to clinical demand for mid-sized labs.
By integrating co-oximetry and ABG, labs can avoid delays and inefficiencies of running separate tests. This ensures critical information reaches clinicians faster.
A major advantage of refurbished analyzer offerings is flexibility.
Facilities can choose analyzers with analyzer menus already configured for co-oximetry or select systems with add-on modules to expand their test capability later.
An example:
This adaptability is very valuable for smaller facilities or clinics. They can start with essential ABG functionality and add co-oximetry later as clinical demand grows without investing in an entirely new analyzer.
The Down-To-Frame® refurbishment process ensures that refurbished analyzers perform like new. Each unit goes through a six step process.
This includes:
For labs, this process allows access to high-end analyzers with co-oximetry capabilities at a fraction of the cost of new systems.
Even the most advanced analyzer requires a strong quality assurance. Accuracy is a critical factor for carboxyhemoglobin and methemoglobin testing since treatment decisions hinge on precise values.
A trusted vendor helps to support labs with quality control products that can verify an analyzer’s performance across blood gas, electrolyte, metabolite and co-oximetry parameters.
Paired with their refurbishment standards, labs can trust that their results are both reproducible and compliant with regulatory requirements.
CO-oximetry fills a critical gap in modern diagnostics. Through direct measurements of hemoglobin species, it prevents clinicians from being misled by apparently normal ABG or pulse oximetry results.
Whether in the context of smoke inhalation testing, treatment monitoring CO poisoning, identifying methemoglobinemia causes or enhancing ICU respiratory failure testing, co-oximetry provides clarity where mattered most. In neonatal care, its role is more crucial by ensuring patients are monitored with accuracy.
For labs, implementing co-oximetry is both a clinical necessity and a strategic investment.
With analyzer menus, add-on module options and cost-effective refurbished systems like the Siemens RAPIDLab 1265 and Siemens RAPIDLab 348, modern vendors offer scalable solutions. The Down-To-Frame® refurbishment service guarantees reliability, accuracy and compliance.
Ultimately, CO-oximetry transforms testing from partial insight into complete understanding. It empowers clinicians to act with confidence and helps save valuable time in emergencies.
In the modern era, CO-oximetry is not considered optional anymore but it is a vital piece to safeguard patient outcomes.
The names and logos of manufacturers, their instruments, and their products referred to herein may be protected by trademark or other law, and are used herein solely for purpose of reference. Products are available for international distribution only unless otherwise indicated. Diamond Diagnostics expressly disclaims any affiliation with products it does not manufacture, as well as sponsorship by other manufacturers. For current regulatory status on products within this website, please contact your sales representative. Prices and Information shown are for reference only and may change without notice. SmartLyte®, ProLyte®, CareLyte®, and Down-To-Frame® Refurbishing are Registered Trademarks of Diamond Diagnostics®. No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. All the above categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.